A sample of this report is available upon request @ http://www.persistencemarketresearch.com/samples/15094
Analytical studies of complex environmental & biological samples demand advanced techniques that help them accomplish multiple analysis synergistically. Liquid chromatography-mass spectroscopy is one such efficient technique that serves the purpose of both – separating the sample mixtures with multiple components and providing structural identity to these individual components. The demand for liquid chromatography-mass spectroscopy (LC-MS) technique is expected to surge due to rising need for advanced analytical measures in the field of biotechnology, food processing, cosmetic & agrochemical production, pharmaceuticals, and environmental monitoring.
Browse Complete Report @ http://www.persistencemarketresearch.com/market-research/liquid-chromatographymass-spectroscopy-market.asp
The report also reveals the impact of triple-quadrupole liquid chromatography-mass spectroscopy on clinical analysis of samples. The demand for triple-quadrupole LC-MS is increasing in clinical analysis, owing to largely improved ionization source and front end ion optics of LC-MS system. According to the report, more than 50% of the global LC-MS market revenues will be accounted by triple-quadrupole (QqQ) technology, throughout the forecast period.
Furthermore, leading players in the global liquid chromatography-mass spectroscopy market such as Thermo Fisher Scientific, Inc. are intensifying their spending on R&D of analytical instruments, which is favoring the market’s growth at considerable extent. Other leading participants in global market for LC-MS technique include Danaher Corporation, PerkinElmer Inc., JEOL Ltd., Bruker Corporation, Agilent Technologies, Waters Corporation, and Shimadzu Corporation.
Request to view table of content @ http://www.persistencemarketresearch.com/market-research/liquid-chromatographymass-spectroscopy-market/toc
Apropos the report findings, demand for liquid chromatography-mass spectroscopy technique will remain higher in clinical testing and environmental testing, revenues from which are anticipated to soar at 8% and 8.7% CAGRs respectively. Drug discovery and development, on the other hand, will be observed as the largest application of liquid chromatography-mass spectroscopy, procuring over one-third share of global revenues towards the end of 2024. The report identifies academic research institutions and contract research organizations as key end-users of liquid chromatography-mass spectroscopy. The use of LC-MS technique in biopharmaceutical companies, however, will record fastest revenue growth at 9.9% CAGR.